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a century now. Since Roentgen’s first radiograph in 1895, the
medical imaging community has made tremendous advances
with imaging technology, leading to earlier detection
of disease, minimally invasive approaches to diagnosis
and therapy, and, most importantly, improved patient
outcome.
Ionizing radiation can directly damage tissue and is
recognized by multiple national and international bodies as
a weak carcinogen [1e3]. Direct tissue damage is referred to
as the deterministic effect of radiation and will occur after
the patient receives a radiation dose that exceeds a threshold,
whereas the risk of cancer is referred to as a random or
stochastic effect, with the probability of developing cancer
increasing with increasing radiation dose to the patient. Both
deterministic and stochastic effects are a function of* Address for correspondence: Yogesh Thakur, PhD, Radiology Admins-
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http://dx.doi.org/10.1016/j.carj.2011.12.012radiation dose, a concept with multiple terminologies that
has led to significant confusion in practice. With an increased
reliance on medical imaging for patient care, both the short-
and long-term risks associated with each imaging procedure
must be understood by all practitioners. The Canadian
Association of Radiologists (CAR) has formed the Radiation
Protection Working Group (RPWG) to provide leadership on
dose education in Canada. This group aims to develop
standards on diagnostic medical radiation protection to
decrease patient risk and provide the CAR membership with
information, online dose-calculating tools, and a forum to
discuss medical radiation dose in Canada.
In this first essay, 3 important concepts will be discussed:
radiation risk models, radiation units and the dose delivered
by medical imaging systems, and the estimated radiation
dose received by the patient. Because computed tomographic
(CT) examinations account for the majority of total radiation
received by patients, especially when considering the
disproportionately lower examination frequency compared
with other medical imaging examinations [4,5], these
concepts will be discussed with a specific emphasize on dose
from common CT examinations.ll rights reserved.
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Biologic damage from radiation exposure is classified as
either deterministic effects on tissue or stochastic effects on
cells. Understanding the models used to predict the effects of
radiation are valuable towards understanding the radiation
protection principles and dose-optimization strategies.
Deterministic effects occur after the absorbed dose exceeds
a dose threshold that leads to an observable biologic change,
which usually is a result of an inflammatory response by the
organ or a reaction to cellular death. The severity of the
tissue reaction increases with the magnitude of the radiation
dose. At a low radiation dose, cellular death may occur but
may not result in an inflammatory response nor result in any
impairment in organ function. However, as radiation dose
exceeds the dose threshold, observable biologic changes will
occur. Increased dose will lead to more severe tissue reac-
tions. Larger doses will result in temporary organ impairment
or death [1,6,7]. In radiology, the vast majority of procedures
should not result in a deterministic effect, because the
radiation doses used in diagnostic imaging are magnitudes
lower than the threshold doses required for the onset of
the following: transient erythema (threshold of approxi-
mately 2 Gy), temporary epilation (threshold of approxi-
mately 3 Gy), and main erythema (threshold of
approximately 6 Gy). Radiologists who perform CT perfu-
sion studies and long interventional procedures should be
aware of these dose thresholds levels and formulate an action
plan if patient dose exceeds these levels.
Contrary to deterministic effects, stochastic effects do not
occur after a dose threshold nor does the severity of the
stochastic effect increase with radiation dose. For instance,
a 1-Gy exposure that leads to a solid cancer is no different
than a 5-Gy exposure that leads to the same solid cancer.
Instead, it is believed that the radiation dose will increase the
probability of a stochastic effect that occurs, that is, the long-
term potential of cancer or hereditary effects will increase
with radiation dose. Three dose-risk models have been
developed by the Biological Effects of Ionizing Radiation
(BEIR) VII [2] of the National Research Council, the linear
no-threshold (LNT) model, linear quadratic model, and the
linear model with threshold. The LNT model has been
widely adopted by international bodies (International
Commission on Radiological Protection, National Council
on Radiation Protection, National Research Council, and
International Atomic Energy Agency) as the method of
estimated incidence of cancer and mortality due to radiation
exposure. This model has been extrapolated from the cohort
of Japanese atomic bomb survivors in Hiroshima and
Nagasaki through the Life Span Study (LSS). The LNT
model is reviewed periodically when new literature becomes
available from medically exposed persons and nuclear
energy workers.
The LNT model is derived from atomic bomb survivors,
where the radiation dose to the survivors is higher in both
rate and quantity, than the radiation used in medical imaging
examinations. At low-exposure levels, statistical limitationsmake it difficult to evaluate cancer risk in humans (BEIR VII
[2, page 7]), which leads to a debate on the validity of the
LNT model applied to low-dose medical examinations. This
debate has led to the ‘‘as low as reasonably achievable’’
(ALARA) principle for radiation protection. Simply put,
because we do not know the full extent of biologic changes
caused by radiation exposure, we must use as little radiation
as possible when obtaining diagnostic quality images. By
proceeding in this fashion, if low-level radiation results in
stochastic effects, then these effects will be mitigated in
future generations.
Radiation Dose Units in Diagnostic Imaging
A variety of radiation terms and units have been described
over the years. In diagnostic imaging, the terms exposure
(units: roentgen or coulombs per kilogram), activity (units:
curie or becquerel), air KERMA (kinetic energy released per
unit mass in air, units: gray), absorbed dose (units: rad or
gray), equivalent dose (units: rem or sievert), and effective
dose (units: rem or sievert) are commonly found in the
literature. Our committee agrees with the current literature
that as non-SI units, the roentgen, curie, rad, and rem should
no longer be used in Canada.
When comparing the radiation output of equipment, the
simplest measurement of radiation delivered is the absorbed
dose in air. Absorbed dose is the amount of energy deposited
within a unit mass, typically measured in air within an
ionization chamber. Absorbed dose has the units of joules per
kilogram (J/kg) and is designated by the SI unit: gray (Gy).
Medical physicists and equipment manufacturers routinely
use absorbed dose measures to easily and quickly determine
whether equipment is producing radiation within defined
standards. The application of absorbed dose to describe
radiation exposure in medicine is only useful if the entire
patient is uniformly exposed, such as fetal radiation expo-
sure, or if the skin entrance dose is monitored for deter-
ministic effects, which may occur in long fluoroscopic
procedures or CT perfusion studies.
The majority of medical imaging procedures focuses on
imaging a specific region of interest (eg, a chest CT), and
these procedures do not irradiate the entire body. For this
reason, absorbed dose is not used to measure patient expo-
sures because this dose does not account for the type of
radiation or the radiosensitivities of the irradiated organs.
When describing the risk associated with radiology
examinations, the best single descriptor is the effective dose,
described in SI units as the sievert (Sv). The sievert incor-
porates both the type of radiation (x-ray vs gamma ray vs
particulate), which have different radiobiologic effectiveness
and organ radiosensitivity. The effective dose allows one to
compare the radiation risk among different imaging modal-
ities (eg, CT vs nuclear medicine), different body part (CT
chest vs CT head), and to compare a medical imaging
examination with natural background radiation. For example,
the radiation received by a patient in nuclear medicine is
related to the activity of the radioisotope administered, target
Table 1
Diagnostic reference levels for typical computed tomography examinationsa
Country, reference no.
Anatomic region (mGy $ cm)
Head Abdomen
Abdomen
and pelvis Chest
United Kingdom [15] 787 472 534 488
Europe [18] 1050 780 e 650
Multinational [16]b 527 696 e 447
British Columbia [19] 1300 920 1100 600
Quebec [20] 1352 823 850 496
a Expressed as dose-length product; the doses were established from only
a few scanners from each nation: Canada (2 scanners), United Kingdom
(1 scanner), Greece (1 scanner), India (2 scanners), Poland (1 scanner), and
Thailand (2 scanners).
b Includes data from Canada, United Kingdom, Greece, India, Poland, and
Thailand.
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the radiation received by a patient in CT is related to the
dose-length product (DLP) (defined in next section). Neither
of these quantities can be directly compared. Instead, phys-
icists have developed methods (Medical Internal Radiation
Dose and Monte Carlo simulations) [8,9] to convert activity
and DLP to effective dose. These conversions enable the
comparison of radiation risk among imaging modalities. For
instance, a scintography ventilation perfusion study has an
effective dose of 3 millisieverts (mSv) [6], whereas a chest
CT has an effective dose of 5-13 mSv [3,9e11]. Although
the radiation from the examinations is different, their risks
can be compared by using effective dose calculations; in this
case, the CT examination has 2-3 times more risk than the
nuclear medicine examination. By using the E, we can
estimate the risk of fatal cancer induction for a reference
subject as 5 excess fatal cancers per 100,000 persons exposed
to 1 mSv. This value will be inaccurate for any individual but
reflects the increased risk for a large population [1].
CT Dose Indicators and Their Utility in Dose
Monitoring
Calculating the effective dose from an ionizing radiation
examination for an individual patient is not a trivial task.
Many factors will influence the effective dose received by the
patient, including imaging modality, imaging parameters
(kVp, mAs, filtration), patient habitus (body mass index,
weight distribution over imaged area, and implants), and
technique (patient positioning and scan area). Due to these
factors, the dose delivered to the patient should be referred to
as the estimated effective dose, or E.
In CT, E is calculated by multiplying the DLP by a body-
specific conversion factor (the k factor) [11e14]. The DLP is
the product of the weighted or volume CT dose index
(CTDIw, CTDIvoldthe radiation delivered to a phantom over
1 gantry rotation and corrected for table pitch) and the scan
length of the examination, with the unit: mGy $ cm. It is very
important to note the CTDIvol, and, thus, the DLP is the dose
to a phantom of a specific size and when using a specific
beam-hardening filter in the system. For an adult head or
body scan, the diameter of the phantom used to calculate the
CTDIvol is 16 cm and 32 cm, respectively. The beam-
hardening filter is used by the system to correct for beam
hardening caused by differences in patient thickness. When
the patient has a diameter and density different from the
phantom size, the CTDIvol can only provide an estimate of
patient dose, which may be either under- or overestimated.
The underlying physics of this problem is well beyond the
scope of this essay. However, it is important for all practi-
tioners to understand that the DLP is a dose indicator. In
addition, the k-factor for a specific examination can change
with a better understanding of the deleterious biologic effects
of ionizing radiation. Understanding the variability in both of
these factors is fundamental to realizing that effective dose
calculation is an estimate and must be treated as an estimate.
For this reason, including E measurements in radiologyreports at this time may be counterproductive due to the
inaccuracy of the measurement.
Although E provides the estimated effective dose and
DLP is a dose indicator, each metric can play a vital role in
CT dose awareness and reduction. The E should be used to
compare the estimated radiation dose from different imaging
modalities, as demonstrated in the previous example. In
addition, E may be used to alleviate patient concerns
regarding radiation from CT examinations by providing
a comparison of E with the amount of annual natural back-
ground radiation received by the public (approximately
2 mSv in Canada).
Practitioners need to be familiar with the dose indicator
DLP because it is the factor that can be easily monitored.
Consequently, it is the CAR recommendation that practi-
tioners review the DLP for each examination performed and
compare them with established diagnostic reference levels
(DRLs) (defined below), which can be easily accomplished
by reviewing the dose report page that accompanies each CT
study. In the event that this page is not available, institutions
should contact their vendor to enable this feature.
Diagnostic Reference Levels (DRLs) in Canada
DRLs are used in medical imaging by physicians and
medical physicists to compare the dose delivered by their
imaging protocols with imaging protocols for the same
examinations at different institutions. These reference values
are defined as the 75th percentile of the patient dose distri-
bution in the form of the dose indicator DLP, from CT
scanners across multiple hospitals for the same examination
(eg, head CT). Health Canada’s Safety Code 35 provides
a table of representative DRL values for common diagnostic
procedures [3]. In CT, practitioners can compare typical DLP
values at their institution with the values published in Safety
Code 35 and in the literature [3,15e18] and listed in Table 1.
Institutional DLP values substantially higher than published
DRL values may indicate a suboptimal protocol, which may
be lowered through imaging technique changes, imple-
menting new technology, and education. It is important to
note that DRLs are not static values and should shift over
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combined with a periodic review and optimization of current
protocols will shift the examination dose distribution to
lower doses, thus resulting in a lower DRL for a given
examination (and technology) over time.
In the DRL values listed in Table 1, Canadian data are only
available from British Columbia and Quebec [16,19,20].
Differences in CT technology (number of slices, scanner
generation) and CT imaging protocols (eg, the start and end
point of a cardiac scan, coverage of CT angiogram) can
contribute to large variations in published DRLs, as shown in
Table 1. It, therefore, is the CARRPWG’smandate to establish
DRLs that reflect CT imaging practices across Canada.
The CAR RPWG
This essay highlighted appropriate dose metrics for radi-
ology practice in Canada and described the utility of the DLP
as a dose indicator for CT examinations. Future essays by the
CAR RPWG will focus on the application of the dose area
product as a dose indicator for radiographic and radioscopic
examinations and establishing Canadian DRLs for CT,
radiography, and radioscopy examinations.
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